← Evidence map

ArticleTherapeutic innovation & regulatory science2025

Pharmaceutical Company's Choices of Indication for the First Clinical Projects in Oncological Drug Development in the United States.

Can Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39480630